IRCT138712141743N1已完成未知
Memantine add on to treatment of refractory obssessive compulsive disorder
Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Suffering from OCD, taking a therapeutic dose of a SSRI or Clomipramine, at least for 12 weeks, Y_BOSC score of 16 or greater Exclusion criteria: primary diagnosis of psychosis or bipolar mood disorder, substance abuse or dependency, uncontrolled medical condition, having had a pervious trial of Memantine, pregnancy or breast feeding, rising liver enzymes to more than twice of normal range during intervention, presence of MDD
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Memantine in the treatment of obsessive-compulsive disorderObsessive-compulsive disorderIRCT201106031556N22Tehran University of Medical Sciences40
进行中（未招募）
1 期
Pharmacological treatment with memantine of oscilloscopy in patients suffering from multiple sclerosis: randomized,double blind placebo controlled study. - NDMedDRA version: 9.1Level: LLTClassification code 10028053Term: MSmultiple sclerosisEUCTR2008-000490-37-ITOSPEDALE S. RAFFAELE40
已完成
3 期
se of memantin in treatment of adult with attention deficit hyperactivity disorderAdult ADHD (Attention-deficit hyperactivity disorder ).Disturbance of activity and attentionIRCT2016053028182N1Kurdistan University of Medical science40
已完成
3 期
adding memantine to treatment of schozophereniaSchizophreniaIRCT20180301038906N1Mashhad University of Medical Sciences60
招募中
不适用
Memantine for treatment of Obsessive-Compulsive DisorderObsessive-compulsive disorderIRCT20170123032145N4Iran University of Medical Sciences44